Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Targeted Drugs for NSCLC
1.2 Key Market Segments
1.2.1 Targeted Drugs for NSCLC Segment by Type
1.2.2 Targeted Drugs for NSCLC Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Targeted Drugs for NSCLC Market Overview
2.1 Global Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Targeted Drugs for NSCLC Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Targeted Drugs for NSCLC Market Competitive Landscape
3.1 Global Targeted Drugs for NSCLC Sales by Manufacturers (2019-2024)
3.2 Global Targeted Drugs for NSCLC Revenue Market Share by Manufacturers (2019-2024)
3.3 Targeted Drugs for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Targeted Drugs for NSCLC Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Targeted Drugs for NSCLC Sales Sites, Area Served, Product Type
3.6 Targeted Drugs for NSCLC Market Competitive Situation and Trends
3.6.1 Targeted Drugs for NSCLC Market Concentration Rate
3.6.2 Global 5 and 10 Largest Targeted Drugs for NSCLC Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Targeted Drugs for NSCLC Industry Chain Analysis
4.1 Targeted Drugs for NSCLC Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Targeted Drugs for NSCLC Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Targeted Drugs for NSCLC Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Drugs for NSCLC Sales Market Share by Type (2019-2024)
6.3 Global Targeted Drugs for NSCLC Market Size Market Share by Type (2019-2024)
6.4 Global Targeted Drugs for NSCLC Price by Type (2019-2024)
7 Targeted Drugs for NSCLC Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Drugs for NSCLC Market Sales by Application (2019-2024)
7.3 Global Targeted Drugs for NSCLC Market Size (M USD) by Application (2019-2024)
7.4 Global Targeted Drugs for NSCLC Sales Growth Rate by Application (2019-2024)
8 Targeted Drugs for NSCLC Market Segmentation by Region
8.1 Global Targeted Drugs for NSCLC Sales by Region
8.1.1 Global Targeted Drugs for NSCLC Sales by Region
8.1.2 Global Targeted Drugs for NSCLC Sales Market Share by Region
8.2 North America
8.2.1 North America Targeted Drugs for NSCLC Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Targeted Drugs for NSCLC Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Targeted Drugs for NSCLC Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Targeted Drugs for NSCLC Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Targeted Drugs for NSCLC Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Targeted Drugs for NSCLC Basic Information
9.1.2 Allergan Targeted Drugs for NSCLC Product Overview
9.1.3 Allergan Targeted Drugs for NSCLC Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Targeted Drugs for NSCLC SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Amgen
9.2.1 Amgen Targeted Drugs for NSCLC Basic Information
9.2.2 Amgen Targeted Drugs for NSCLC Product Overview
9.2.3 Amgen Targeted Drugs for NSCLC Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Targeted Drugs for NSCLC SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 ARIAD Pharmaceuticals (Takeda)
9.3.1 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Basic Information
9.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Overview
9.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Market Performance
9.3.4 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC SWOT Analysis
9.3.5 ARIAD Pharmaceuticals (Takeda) Business Overview
9.3.6 ARIAD Pharmaceuticals (Takeda) Recent Developments
9.4 Beacon Pharma Limited
9.4.1 Beacon Pharma Limited Targeted Drugs for NSCLC Basic Information
9.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Overview
9.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Product Market Performance
9.4.4 Beacon Pharma Limited Business Overview
9.4.5 Beacon Pharma Limited Recent Developments
9.5 BeiGene
9.5.1 BeiGene Targeted Drugs for NSCLC Basic Information
9.5.2 BeiGene Targeted Drugs for NSCLC Product Overview
9.5.3 BeiGene Targeted Drugs for NSCLC Product Market Performance
9.5.4 BeiGene Business Overview
9.5.5 BeiGene Recent Developments
9.6 Biocon
9.6.1 Biocon Targeted Drugs for NSCLC Basic Information
9.6.2 Biocon Targeted Drugs for NSCLC Product Overview
9.6.3 Biocon Targeted Drugs for NSCLC Product Market Performance
9.6.4 Biocon Business Overview
9.6.5 Biocon Recent Developments
9.7 Boehringer-Ingelheim
9.7.1 Boehringer-Ingelheim Targeted Drugs for NSCLC Basic Information
9.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Overview
9.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Market Performance
9.7.4 Boehringer-Ingelheim Business Overview
9.7.5 Boehringer-Ingelheim Recent Developments
9.8 Celgene Corporation
9.8.1 Celgene Corporation Targeted Drugs for NSCLC Basic Information
9.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Overview
9.8.3 Celgene Corporation Targeted Drugs for NSCLC Product Market Performance
9.8.4 Celgene Corporation Business Overview
9.8.5 Celgene Corporation Recent Developments
9.9 Drug International Limted
9.9.1 Drug International Limted Targeted Drugs for NSCLC Basic Information
9.9.2 Drug International Limted Targeted Drugs for NSCLC Product Overview
9.9.3 Drug International Limted Targeted Drugs for NSCLC Product Market Performance
9.9.4 Drug International Limted Business Overview
9.9.5 Drug International Limted Recent Developments
9.10 Fujifilm Kyowa Kirin Biologics
9.10.1 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Basic Information
9.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Overview
9.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Market Performance
9.10.4 Fujifilm Kyowa Kirin Biologics Business Overview
9.10.5 Fujifilm Kyowa Kirin Biologics Recent Developments
9.11 Genvio Pharma Limited
9.11.1 Genvio Pharma Limited Targeted Drugs for NSCLC Basic Information
9.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Overview
9.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Product Market Performance
9.11.4 Genvio Pharma Limited Business Overview
9.11.5 Genvio Pharma Limited Recent Developments
9.12 Hetero Drugs
9.12.1 Hetero Drugs Targeted Drugs for NSCLC Basic Information
9.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Overview
9.12.3 Hetero Drugs Targeted Drugs for NSCLC Product Market Performance
9.12.4 Hetero Drugs Business Overview
9.12.5 Hetero Drugs Recent Developments
9.13 ImClone Systems (Eli Lilly)
9.13.1 ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Basic Information
9.13.2 ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Product Overview
9.13.3 ImClone Systems (Eli Lilly) Targeted Drugs for NSCLC Product Market Performance
9.13.4 ImClone Systems (Eli Lilly) Business Overview
9.13.5 ImClone Systems (Eli Lilly) Recent Developments
9.14 Incepta Pharmaceuticals
9.14.1 Incepta Pharmaceuticals Targeted Drugs for NSCLC Basic Information
9.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Overview
9.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Market Performance
9.14.4 Incepta Pharmaceuticals Business Overview
9.14.5 Incepta Pharmaceuticals Recent Developments
9.15 Mylan
9.15.1 Mylan Targeted Drugs for NSCLC Basic Information
9.15.2 Mylan Targeted Drugs for NSCLC Product Overview
9.15.3 Mylan Targeted Drugs for NSCLC Product Market Performance
9.15.4 Mylan Business Overview
9.15.5 Mylan Recent Developments
9.16 Novartis
9.16.1 Novartis Targeted Drugs for NSCLC Basic Information
9.16.2 Novartis Targeted Drugs for NSCLC Product Overview
9.16.3 Novartis Targeted Drugs for NSCLC Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 Pfizer
9.17.1 Pfizer Targeted Drugs for NSCLC Basic Information
9.17.2 Pfizer Targeted Drugs for NSCLC Product Overview
9.17.3 Pfizer Targeted Drugs for NSCLC Product Market Performance
9.17.4 Pfizer Business Overview
9.17.5 Pfizer Recent Developments
9.18 Reliance Lifesciences
9.18.1 Reliance Lifesciences Targeted Drugs for NSCLC Basic Information
9.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Overview
9.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Product Market Performance
9.18.4 Reliance Lifesciences Business Overview
9.18.5 Reliance Lifesciences Recent Developments
9.19 Roche
9.19.1 Roche Targeted Drugs for NSCLC Basic Information
9.19.2 Roche Targeted Drugs for NSCLC Product Overview
9.19.3 Roche Targeted Drugs for NSCLC Product Market Performance
9.19.4 Roche Business Overview
9.19.5 Roche Recent Developments
9.20 AstraZeneca
9.20.1 AstraZeneca Targeted Drugs for NSCLC Basic Information
9.20.2 AstraZeneca Targeted Drugs for NSCLC Product Overview
9.20.3 AstraZeneca Targeted Drugs for NSCLC Product Market Performance
9.20.4 AstraZeneca Business Overview
9.20.5 AstraZeneca Recent Developments
9.21 Cipla
9.21.1 Cipla Targeted Drugs for NSCLC Basic Information
9.21.2 Cipla Targeted Drugs for NSCLC Product Overview
9.21.3 Cipla Targeted Drugs for NSCLC Product Market Performance
9.21.4 Cipla Business Overview
9.21.5 Cipla Recent Developments
9.22 Teva
9.22.1 Teva Targeted Drugs for NSCLC Basic Information
9.22.2 Teva Targeted Drugs for NSCLC Product Overview
9.22.3 Teva Targeted Drugs for NSCLC Product Market Performance
9.22.4 Teva Business Overview
9.22.5 Teva Recent Developments
9.23 OSI Pharmaceuticals
9.23.1 OSI Pharmaceuticals Targeted Drugs for NSCLC Basic Information
9.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Overview
9.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Market Performance
9.23.4 OSI Pharmaceuticals Business Overview
9.23.5 OSI Pharmaceuticals Recent Developments
9.24 Glenmark Pharmaceuticals
9.24.1 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Basic Information
9.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Overview
9.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Market Performance
9.24.4 Glenmark Pharmaceuticals Business Overview
9.24.5 Glenmark Pharmaceuticals Recent Developments
9.25 Natco Pharma
9.25.1 Natco Pharma Targeted Drugs for NSCLC Basic Information
9.25.2 Natco Pharma Targeted Drugs for NSCLC Product Overview
9.25.3 Natco Pharma Targeted Drugs for NSCLC Product Market Performance
9.25.4 Natco Pharma Business Overview
9.25.5 Natco Pharma Recent Developments
10 Targeted Drugs for NSCLC Market Forecast by Region
10.1 Global Targeted Drugs for NSCLC Market Size Forecast
10.2 Global Targeted Drugs for NSCLC Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Targeted Drugs for NSCLC Market Size Forecast by Country
10.2.3 Asia Pacific Targeted Drugs for NSCLC Market Size Forecast by Region
10.2.4 South America Targeted Drugs for NSCLC Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Targeted Drugs for NSCLC by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Targeted Drugs for NSCLC Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Targeted Drugs for NSCLC by Type (2025-2030)
11.1.2 Global Targeted Drugs for NSCLC Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Targeted Drugs for NSCLC by Type (2025-2030)
11.2 Global Targeted Drugs for NSCLC Market Forecast by Application (2025-2030)
11.2.1 Global Targeted Drugs for NSCLC Sales (K Units) Forecast by Application
11.2.2 Global Targeted Drugs for NSCLC Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
